Afdahl David Martin sold 28,319 shares of IBEX Ltd at $56.35 for −$1.60M on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Operating Officer
Chief Operating Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,595,883.26Shares × reported price
Shares traded
28,319Common Shares
Price per share
$56.35Reported price. Read footnotes for ranges.
% of reported position traded
16.79%This security and ownership context
Holdings after
140,325Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 17, 2026, 7:12 PM ET2-day reporting delay
Accession
0001974087-26-000015Code S · Transaction 404723
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 168,644 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Option exercise17,500$12.75$223,125Trade 404721
Nov 16, 2026Option exercise10,819$19.00$205,561Trade 404722
Nov 16, 2026Option exercise17,500$0.00$0Trade 404724
Nov 16, 2026Option exercise10,819$0.00$0Trade 404725
5 transaction rows in this filing. Joint filers share the same rows.

IBEX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IBEX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −18%1w ago −9.4%1d ago +2.6%
Returns since7d30d90d180d1y

Footnotes in full

F1: Reflects a cashless exercise and same-day sale of shares. This transaction was executed in multiple trades at prices ranging from $55.59 to $57.01; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F2: The shares subject to this option were fully vested and exercisable as of June 1, 2023. F3: The shares subject to this option were fully vested and exercisable as of August 1, 2022.